Creating a new imaging tool to detect a cancer-related protein

Develop a PET radiotracer suitable for in vivo imaging of TGFβ

NIH-funded research Providence Health & Services - Oregon · NIH-10954218

This study is testing a new imaging tool that can help doctors see and measure a protein called TGFβ, which is important for understanding how cancer is behaving, and it's being tested in mice to see how well it works.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionProvidence Health & Services - Oregon NIH-funded
Lab location1 site (Renton, United States)
Project IDNIH-10954218 on NIH RePORTER

What this research studies

This research focuses on developing a novel PET radiotracer that can non-invasively detect the levels of TGFβ, a protein linked to poor cancer outcomes. By using a specially designed protein that binds to TGFβ, the researchers aim to create a tool that can visualize and quantify this protein in living organisms. The study will involve testing this radiotracer in mice to determine its effectiveness and optimal usage. If successful, this approach could provide valuable insights into cancer progression and treatment responses.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients with cancers known to have high levels of TGFβ and who are undergoing treatment.

Not a fit: Patients with non-cancerous conditions or those whose cancers do not involve TGFβ may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer prognosis assessments and more personalized treatment strategies for patients.

How similar studies have performed: Previous research has shown promise in using PET imaging for other biomarkers, suggesting potential success for this novel approach.

Where this research is happening

Renton, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Prognosis
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.